Loading...
OTCM
BLNC
Market cap72mUSD
Dec 11, Last price  
1.55USD
Name

Balance Labs Inc

Chart & Performance

D1W1MN
OTCM:BLNC chart
P/E
P/S
12,103.52
EPS
Div Yield, %
Shrs. gr., 5y
3.49%
Rev. gr., 5y
-64.06%
Revenues
6k
190,28639,00005006,6673,3331,000,000624,590247,500006,000
Net income
-32m
L+5,916.73%
-14,481-366,000-1,135,000-839,000-548,000-884,000246,429-797,000-768,000-381,571-528,000-31,768,325
CFO
-257k
L+63.59%
112,377-202,602-635,073-372,332-420,269-365,608-218,002-56,8967,753-122,502-157,110-257,024

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Balance Labs, Inc. functions as a specialized consultancy, delivering business development and strategic guidance to emerging and growth-phase companies in both domestic U.S. and international markets. The firm assists diverse enterprises in fine-tuning their core business frameworks, optimizing sales and marketing strategies, and improving internal operations. It also acts as a conduit, providing introductions to vital professional services, such as business plan formulation, accounting expertise, and legal support. Beyond these foundational services, Balance Labs plays an active role in the conceptualization and implementation of a broad spectrum of initiatives. This includes holistic business model design (encompassing market analysis, nomenclature, and brand identity), sophisticated financial modeling, the creation of websites and mobile applications, and the strategic recruitment of both staff and board members. The company further extends its support to patent and trademark application processes, product or service innovation and manufacturing, the development of compelling marketing collateral, strategic product/service positioning, the procurement of celebrity endorsements, and connecting clients with specialized legal and accounting professionals. Established in 2014 and headquartered in Miami Beach, Florida, Balance Labs, Inc. is a wholly-owned subsidiary of Balance Holdings, LLC.
IPO date
Oct 20, 2015
Employees
4
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT